Paradigm reports 5.16% stake in Integra LifeSciences

Integra LifeSciences Holdings Corp ownership disclosure: Paradigm Capital Management, Inc. reports 4,012,698 shares of Common Stock, representing 5.16% of the class as of 03/31/2026.

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp ownership disclosure: Paradigm Capital Management, Inc. reports 4,012,698 shares of Common Stock, representing 5.16% of the class as of 03/31/2026. The filing states these securities are owned by advisory clients and Paradigm has sole voting and dispositive power over these shares.

Insights

Institutional Ownership Analyst

Passive institutional stake above the 5% reporting threshold.

Paradigm Capital Management, Inc. reports beneficial ownership of 4,012,698 shares (5.16%) of Integra LifeSciences Common Stock as of 03/31/2026. The filing identifies sole voting and dispositive power for those shares.

The disclosure notes the shares are owned by advisory clients rather than the firm itself; this is a common structure for investment advisers and signals aggregated client holdings crossing the 5% reporting threshold. Subsequent filings may show changes if advisory clients rebalance.

Securities Compliance Counsel

Schedule 13G filing is a routine regulatory disclosure for passive investors.

The filing is a Schedule 13G disclosure signed by the reporting person’s CCO on 05/15/2026, referencing holdings as of 03/31/2026. It states ownership is on behalf of advisory clients, consistent with passive investor reporting conventions.

Careful readers should note the filing attributes sole voting and dispositive power to Paradigm for these shares; voting/control mechanics are disclosed verbatim in the text.

Key Figures

Shares beneficially owned: 4,012,698 shares Percent of class: 5.16% CUSIP: 457985208 +1 more

4 metrics

Shares beneficially owned 4,012,698 shares Beneficially owned as of 03/31/2026

Percent of class 5.16% Percent of common stock as reported in Item 4(b)

CUSIP 457985208 Integra LifeSciences Common Stock CUSIP

Filing signatory date 05/15/2026 Signature date by Richard Gimon, CCO

Key Terms

Schedule 13G, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G regulatory

"Schedule 13G ownership statement for beneficial owners"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Beneficially owned financial

"Amount beneficially owned: 4012698"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 4012698"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Paradigm Capital report in Integra LifeSciences (IART)?

Paradigm Capital reports beneficial ownership of 4,012,698 shares, equal to 5.16% of Integra LifeSciences Common Stock as of 03/31/2026. The filing attributes sole voting and dispositive power over those shares to Paradigm.

Who beneficially owns the shares reported by Paradigm Capital?

The filing states the reported securities are owned by advisory clients of Paradigm Capital Management, Inc. Paradigm discloses it has sole voting and dispositive power for the 4,012,698 shares listed in the Schedule 13G.

What date does the Schedule 13G use for the ownership count?

The ownership amount is reported as of 03/31/2026. The Schedule 13G was signed on 05/15/2026 by the reporting person’s CCO, which is the attestation date for the filing rather than the ownership snapshot date.

Does the filing indicate whether Paradigm is an active or passive holder?

The filing is a Schedule 13G statement and describes ownership on behalf of advisory clients, which aligns with passive/investment-adviser reporting conventions. It discloses sole voting and dispositive power but does not state any activist intent or plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 11:49 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

INTEGRA LIFESCIENCES HOLDINGS CORP

(Name of Issuer)

Common Stock

(Title of Class of Securities)

457985208

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 457985208

1

Names of Reporting Persons

PARADIGM CAPITAL MANAGEMENT INC/NY

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,012,698.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,012,698.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,012,698.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: INTEGRA LIFESCIENCES HOLDINGS CORP
(b)	Address of issuer's principal executive offices: 1100 CAMPUS ROAD, PRINCETON, NEW JERSEY, 08540
Item 2.
(a)	Name of person filing: Paradigm Capital Management, Inc.
(b)	Address or principal business office or, if none, residence: 9 Elk Street Albany, NY 12207
(c)	Citizenship: New York S Corporation
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 457985208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4012698
(b)	Percent of class: 5.16%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4012698
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4012698
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All securities reported in this Schedule 13G Report are owned by advisory clients of the Reporting Person.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

PARADIGM CAPITAL MANAGEMENT INC/NY

Signature:	Richard Gimon
Name/Title:	CCO
Date:	05/15/2026